다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
European journal of pharmacology, v.517 no.3, 2005년, pp.224 - 231
Shukla, Nilima (Bristol Heart Institute, Department of Cardiac Surgery, Bristol Royal Infirmary, Bristol BS2 8HW, UK) , Jones, Robert (Department of Urology, Bristol Royal Infirmary, UK) , Persad, Raj (Department of Urology, Bristol Royal Infirmary, UK) , Angelini, Gianni D. (Bristol Heart Institute, Department of Cardiac Surgery, Bristol Royal Infirmary, Bristol BS2 8HW, UK) , Jeremy, Jamie Y. (Bristol Heart Institute, Department of Cardiac Surgery, Bristol Royal Infirmary, Bristol BS2 8HW, UK)
AI-Helper
AbstractHypercholesterolaemia promotes erectile dysfunction through increased superoxide formation and negation of nitric oxide (NO) bioactivity in cavernosal tissue. The source of superoxide has not been clearly defined, however. Sildenafil (Viagra™), the standard therapy for erectile dysfunc...
J. Urol. Ballard 159 2164 1998 10.1016/S0022-5347(01)63299-3 Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes
Clin. Cardiol. Barrett-Connor 274 I8 2004 10.1002/clc.4960271304 Cardiovascular risk stratification and cardiovascular risk factors associated with erectile dysfunction: assessing cardiovascular risk in men with erectile dysfunction
J. Urol. Bocchio 171 1601 2004 10.1097/01.ju.0000116325.06572.85 Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage
Br. J. Pharmacol. Cashen 136 693 2002 10.1038/sj.bjp.0704772 Effects of sidenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase
Circulation Cheitlin 99 168 1999 10.1161/01.CIR.99.1.168 ACC/AHA expert consensus document: use of sildenafil (Viagra) in patients with cardiovascular disease
J. Urol. Chuang 160 257 1998 10.1016/S0022-5347(01)63100-8 Sildenafil, a type-5 cGMP phoshodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro
Curr. Med. Res. Opin. Corbin 19 747 2003 10.1185/030079903125002522 Sildenafil citrate does not affect cardiac contractility in human or dog heart
J. Urol. Feldman 151 54 1994 10.1016/S0022-5347(17)34871-1 Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study
Mol. Urol. Gonzalez-Cadavid 3 51 1999 Nitric oxide and the cyclic GMP system in the penis
Circulation Itoh 105 2288 2002 10.1161/01.CIR.0000015607.33345.1F Importance of NAD(P)H oxidase-mediated oxidative stress and contractile type smooth muscle myosin heavy chain SM2 at the early stage of atherosclerosis
Br. J. Urol. Int. Jeremy 79 958 1997 10.1046/j.1464-410X.1997.00206.x Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro
Cardiovasc. Res. Jeremy 46 50 2000 10.1016/S0008-6363(00)00009-2 Platelets, oxidant stress and erectile dysfunction: an hypothesis
Curr. Vasc. Pharmacol. Jeremy 2 229 2004 10.2174/1570161043385691 Reactive oxygen species, vascular disease and cardiovascular surgery
Clin. Pharmacol. Ther. Jetter 71 21 2002 10.1067/mcp.2002.121236 Effects of grapefruit juice on the pharmacokinetics of sildenafil
Expert Opin. Pharmacother. Jones 3 889 2002 10.1517/14656566.3.7.889 Oxygen free radicals and the penis
Br. J. Urol. Int. Jones 95 125 2005 10.1111/j.1464-410X.2004.05263.x Erectile dysfunction in hyperhomocysteinaemic rabbits
Int. J. Impot. Res. Kalsi 16 195 2004 10.1038/sj.ijir.3901157 NCX-911, a novel nitric oxide-releasing PDE5 inhibitor relaxes rabbit corpus cavernosum in the absence of endogenous nitric oxide
Asian J. Androl. Kim 2 161 2000 Hyperlipidemia and erectile dysfunction
Urol. Res. Kim 25 341 1997 10.1007/BF01294663 Involvement of superoxide radical in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolaemic rabbits
Cardiovasc. Res. Kojda 43 562 1999 10.1016/S0008-6363(99)00169-8 Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure
Am. J. Physiol. Li 267 R1014 2004 Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology
J. Urol. Martin-Morales 166 569 2001 10.1016/S0022-5347(05)65986-1 Prevalence and independant risk factors for erectile dysfunction in Spain
J. Androl. McAuley 22 623 2001 10.1002/j.1939-4640.2001.tb02222.x Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathway
Int. J. Impot. Res. Morales 10 69 1998 10.1038/sj.ijir.3900354 Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction
J. Cardiovasc. Pharmacol. Mugge 24 994 1994 10.1097/00005344-199424060-00019 Vascular release of superoxide radicals is enhanced in hypercholesterolaemic rabbits
Thorax Muzaffar 58 598 2003 10.1136/thorax.58.7.598 The role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries
Circulation Muzaffar 110 1140 2004 10.1161/01.CIR.0000139851.50067.E4 Nitroaspirins and morpholino sydnonimine, but not aspirin, inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells
Thorax Muzaffar 60 305 2005 10.1136/thx.2003.018796 Hypoxia simultaneously induces the expression of gp91phox and endothelial nitric oxide synthase which promotes peroxynitrite formation in the pulmonary artery
J. Clin. Invest. O'Hara 91 2546 1993 10.1172/JCI116491 Hypercholesterolaemia increases endothelial superoxide anion production
Eur. Urol. Palumbo 40 176 2001 10.1159/000049769 Sildenafil: efficacy and safety in daily clinical practice
Am. J. Cardiol. Rosen 92 9M 2003 10.1016/S0002-9149(03)00824-5 Overview of phosphodiesterase 5 inhibition in erectile dysfunction
Eur. Urol. Roumeguere 44 355 2003 10.1016/S0302-2838(03)00306-3 Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk
Eur. Urol. Seidler 42 523 2002 10.1016/S0302-2838(02)00397-4 In vitro effects of a novel class of nitric oxide (NO) donating compounds on isolated human erectile tissue
J. Androl. Seo 20 298 1999 10.1002/j.1939-4640.1999.tb02521.x Involvement of endothelial NOS in the impaired endothelium dependent relaxation of cavernosal smooth muscle in hypercholesterolaemic rabbits
Cardiovasc. Res. Sullivan 43 580 1999 10.1016/S0008-6363(99)00135-2 Nitric oxide and erection: is erectile dysfunction another manifestation of vascular disease?
Eur. J. Pharmacol. Thompson 425 57 2001 10.1016/S0014-2999(01)01077-9 Effect of sildenafil (Viagra™) on relaxation of the corpus cavernosum of the diabetic rabbit
Circulation Warnholtz 99 2027 1999 10.1161/01.CIR.99.15.2027 Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis
J. Am. Coll. Cardiol. Webb 36 25 2000 10.1016/S0735-1097(00)00705-1 Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina
Am. J. Epidemiol. Wei 140 930 1994 10.1093/oxfordjournals.aje.a117181 Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.